In a recent ruling, a federal judge in Hawaii found that the U.S. Food and Drug Administration unlawfully restricted access to mifepristone, a medication used for abortions and miscarriage management. The court determined the FDA violated the law by failing to provide a justified explanation for maintaining its restrictions, which include special certifications for prescribers and pharmacies. The ACLU, which brought the lawsuit, argued that the restrictions disproportionately impact patients with limited healthcare access, highlighting the medication’s safety and effectiveness. Although the FDA is instructed to reconsider its stance, the restrictions currently remain in place as the case navigates ongoing political pressures surrounding the medication.
Read More
As reported by the Associated Press, Maine Family Planning, a network of 18 clinics serving low-income residents, is closing its primary care operations due to the Trump administration’s cuts to abortion providers. The network, which offers a range of services beyond abortions, including cancer screenings and STD testing, stated the cuts forced them to make difficult decisions. The move to defund abortion providers is driving patients away from their doctors and has resulted in over 600 patients losing access to care. Maine Family Planning is fighting the funding cuts in federal court, with the Center for Reproductive Rights vowing to continue the legal battle.
Read More
The FDA has approved another generic version of the abortion pill mifepristone, a routine regulatory step. This approval, announced by Evita Solutions, immediately drew criticism from anti-abortion groups and Republican politicians. Despite the FDA’s assertion of limited discretion in generic drug approvals and statements on the safety and efficacy of the drug, some conservatives have expressed concern. The approval of this additional generic version is unlikely to affect access to the drug, which is typically taken in combination with misoprostol, though access to the medication is already restricted in many states.
Read More
The FDA recently approved a request to manufacture a generic version of mifepristone, a drug used in medication abortions, which has drawn sharp criticism from anti-abortion advocates. This approval allows Evita Solutions to produce its version of the drug, despite ongoing efforts to restrict access to mifepristone since the overturning of Roe v Wade. Critics, including some politicians and anti-abortion groups, have expressed outrage and questioned the FDA’s decision, citing safety concerns and recent studies. However, abortion rights supporters and medical professionals maintain that mifepristone is safe and effective, pointing to numerous studies supporting its use.
Read More
Protecting the public from misinformation requires vigilance, especially when it comes to health and medicine. The organization is committed to delivering unbiased, factual reporting to combat the spread of dangerous medical myths. Readers’ past support was crucial to the organization’s success and has allowed them to remain strong. Now, they are calling on readers to join and contribute once more to safeguard science and protect public health.
Read More
HuffPost, a news source dedicated to fact-based journalism, has been operating for two decades and remains committed to its mission. The publication is seeking support to continue its work. Reader contributions have been crucial in building and sustaining their newsroom, particularly during challenging periods. HuffPost hopes readers will continue to support its efforts.
Read More
Grace claimed that Capriglione’s stance on abortion was hypocritical, alleging he funded abortions despite presenting himself as anti-abortion. This is particularly notable as Capriglione authored Texas’s stringent “trigger” abortion ban, which makes performing an abortion a felony. Capriglione admitted to infidelity but denied paying for any abortions, stating his family has forgiven him.
Read More
A federal judge has ruled that Planned Parenthood clinics nationwide must continue to receive Medicaid funding, despite efforts by the Trump administration to defund the organization. The court order blocks the federal government from excluding groups like Planned Parenthood from Medicaid reimbursements, as the organization has a substantial likelihood of success in its legal challenge. This decision is a result of a lawsuit filed by Planned Parenthood, who argued that cutting off Medicaid funds would force nearly 200 clinics to close, impacting over a million patients. The lawsuit challenges a provision in Trump’s tax bill that targeted abortion providers receiving over $800,000 from Medicaid in 2023, even if they provide other medical services.
Read More
In a recent development, a New York county clerk has once again refused to file a Texas civil judgment against a doctor accused of prescribing abortion pills. This decision is based on New York’s shield law, which protects providers from legal actions in states with abortion bans. Despite demands from the Texas Attorney General’s office, the clerk has maintained the rejection, citing New York law. This case, along with another involving extradition to Louisiana, could test the boundaries of state shield laws and the legal battles surrounding abortion access.
Read More
Report: More Texans crossed state lines to get an abortion than anywhere in the U.S.
It’s pretty clear, isn’t it? The sheer size of Texas, combined with its restrictive abortion laws, makes it almost inevitable that a significant number of Texans would seek care elsewhere. This report isn’t just a headline; it’s a direct consequence of political choices. The fact that Texas leads in this grim statistic speaks volumes about the state’s policies and their impact on women’s access to healthcare. It is a reality, and the numbers bear it out.
Report: More Texans crossed state lines to get an abortion than anywhere in the U.S.… Continue reading
John Q. Hosedrinker 
Matt Underwood